Home > PJ > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7186 p233-237
23 February 2002


News summary

News in brief

Nurses to be allowed to prescribe nine antibiotics
Nurses are to be allowed to prescribe nine oral antibiotics for specified conditions in a major extension of prescribing rights for a specially trained section of the profession...[more]

Pharmacists should use buying power to change unsafe packaging and labelling of medicines Hospital pharmacists should use their purchasing power to influence the design of drug packaging and so reduce the potential for medication errors, drug and patient safety experts said this week...[more]

Pharmacies not to supply gluten-free foods on NHS Plans to allow community pharmacies in England to make National Health Service supplies of gluten-free foods to coeliac patients on request have been dropped...[more]

No cannabis medicines before 2004 Prescribing cannabis-based drugs on the National Health Service will not be cleared until 2004–05, following the same sort of exhaustive tests as apply to any newly marketed drugs, the Prime Minister's press spokesman said this week...[more]

£2.5m for research into autism The Government has given the Medical Research Council an additional £2.5m for its research on the epidemiology and causes of autism...[more]

New NICE appraisals New drugs to treat breast cancer, Alzheimer's disease and hepatitis C, and to give pain relief in multiple sclerosis are being considered for the seventh wave of appraisals by the National Institute for Clinical Excellence in April 2003...[more]

Heroin recommended in the Netherlands Diamorphine (heroin) should be prescribable for treatment-resistant addicts, according to the Netherlands' Central Committee on the Treatment of Heroin Addicts...[more]

New faces expected on PSNC this year The Pharmaceutical Services Negotiating Committee will have at least three new faces this year...[more]

GSK profits now top £6bn GLAXOSMITHKLINE reported pre-tax profits of over £6bn for last year on 14 February, citing strong new products as one of the driving forces behind this growth...[more]

Minister is committed, says PSNC The Pharmaceutical Services Negotiating Committee believes that Hazel Blears, Parliamentary Under-Secretary of State for Health, is committed to the future of community pharmacy...[more]

Irish pharmacists threaten court action Pharmacists in the Irish Republic may go to court to try to block the deregulation of the pharmacy market...[more]

Europe proposes regulatory reform Proposals for significant reform to the European system for licensing medicines have been brought forward by the European Commission...[more]

Raised homocysteine is risk factor for Alzheimer's An increased plasma homocysteine level is a strong, independent risk factor for the development of Alzheimer's disease, suggests a study in this week's New England Journal of Medicine...[more]

NICE chairman to present Care Awards Professor Sir Michael Rawlins, chairman of the National Institute for Clinical Excellence, is to speak at the Pharmaceutical Care Awards on 5 July and present the prizes to the winners...[more]

Raloxifene reduces cardiovascular events in older women at CHD risk Raloxifene (Evista) reduces the risk of cardiovascular events in postmenopausal women with osteoporosis who are at increased risk of heart disease, researchers say...[more]

Four cases of etanercept-induced SLE Etanercept (Enbrel), an inhibitor of tumour necrosis factor-alpha (TNF-a), should be considered in the list of agents associated with drug-induced systemic lupus erythematosus (SLE)...[more]

Obese patients not served by guidance Guidelines for the treatment of hypertension fail to provide specific advice on its management in obese patients, said Professor Arya Sharma, Humboldt University of Berlin...[more]

No increased risk of heart attacks with celecoxib Treatment with celecoxib (Celebrex) does not increase risk of heart attack or stroke compared with other non-steroidal anti-inflammatory drugs, researchers say...[more]

Life-member, Reginald Davis, celebrates his centenary next week Reginald Davis, MRPharmS, one of two known surviving life-members of the Royal Pharmaceutical Society, is to celebrate his 100th birthday next week...[more]


NEWS IN BRIEF


Patients prefer pharmacists for obtaining repeat prescriptions Most people would prefer to get repeat prescriptions from their pharmacists, according to a MORI poll commissioned by the British Medical Association. MORI found that 84 per cent of people would be happy to see a pharmacist instead of a general practitioner to get a repeat prescription. The poll also found that 87 per cent of people were happy to see a nurse instead of a doctor if their condition was not serious.

Why cod liver oil stops joint pain Researchers from Cardiff University have confirmed why cod liver oil is effective in treating joint pain. Professor Bruce Caterson found that omega-3 fatty acids can stop the action of the degradative enzymes and inflammatory factors that are involved in breaking down joint cartilage, thus slowing down the progress of cartilage destruction and reducing inflammation and pain. The research is expected to be published this year in Arthritis and Rheumatism.

Honey contaminated with antibiotic The Food Standards Agency has found that many jars of blended honey which include Chinese honey are contaminated with streptomycin, which is classified as an illegal contaminant. Jars in shops are to be removed.
(Food Standards Agency www.food.gov.uk)

Seizure risk for babies exposed to HIV treatment during birth Children born to HIV-infected mothers who receive antiretroviral treatment perinatally, are at higher risk of early febrile seizures, say researchers. The cumulative risk for febrile seizure at 18 months was 11.0±2.2 for children exposed to antiretrovirals versus 4.1±1.7 for those who were not. "The long-term consequences of these early febrile seizures are unknown and not necessarily deleterious. However, these findings prompt careful monitoring of the cognitive and behavioural development of the children concerned," they say (Lancet 2002;359: 583).

MMR population study published The population study that found no association between the measles, mumps and rubella vaccine and a new form of autism (PJ, 16 February, p198) has been published in the BMJ (2002;324:393).


  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal